Using Biomarkers for Precision to CV Medicine, Prevention and Population Health (James de Lemos, MD)
Автор: Houston Methodist DeBakey CV Education
Загружено: 2024-12-05
Просмотров: 1068
Описание:
This grand rounds presentation evaluates pitfalls in the hoped-for transition to precision
medicine in cardiology, and potential steps to move towards these lofty goals.
Objectives:
1. Evaluate the strengths and limitations of currently available cardiovascular risk assessment
approaches and biomarkers, including c-reactive protein, troponins, and natriuretic peptides, for
risk assessment and therapeutic guidance in cardiovascular pre
2. Appropriately use actuarial risk assessment for specific cardiovascular outcomes to help guide
decisions for CVD prevention and treatment.
3. Incorporate risk assessment to enhance population health efforts regarding cardiovascular prevention.
DeBakey Heart & Vascular Center Grand Rounds
JAMES DE LEMOS, MD OF EPISODE: Using Biomarkers to Add Precision to Cardiovascular Medicine, Prevention and Population Health: Hype or Hope?
SPEAKER:
James de Lemos, MD
Chief of Cardiology
UT Southwestern
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
